Sinopharm Group Says Qtrly Total Operating Revenue RMB147.27 Bln
Sinopharm Group Co Ltd 1099:
QTRLY TOTAL OPERATING REVENUE RMB147.27 BILLION VERSUS RMB145.52 BILLION
QTRLY NET PROFIT ATTRIBUTABLE RMB1.42 BILLION VERSUS RMB1.59 BILLION
Sinopharm Group Co Ltd 1099:
QTRLY TOTAL OPERATING REVENUE RMB147.27 BILLION VERSUS RMB145.52 BILLION
QTRLY NET PROFIT ATTRIBUTABLE RMB1.42 BILLION VERSUS RMB1.59 BILLION